PRE — Prenetics Global Ltd

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1876431 ·
Last close
$16.33
Market Cap
$248.19M
52W High
$27.24
52W Low
$11.36
ADV30
188,899
Next earnings
2026-11-18

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 46,488,000 30,203,000 -21,919,000 -8,983,000 153,655,000 59,050,000 60,732,000
Mar 2026 35,954,000 23,283,000 -9,706,000 -23,104,000 175,302,000 56,017,000 54,280,000
Dec 2025 36,558,000 21,588,000 -13,136,000 -7,501,000 206,073,000 32,131,000 49,707,000
Sep 2025 23,555,000 14,024,000 -6,559,000 -7,408,000 196,507,000 13,264,000 35,305,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-37,175,000
Investing CF
$71,870,000
Financing CF
$-37,477,000
CapEx
—
Dividends Paid
$0
Buybacks
$-40,037,000
EPS Diluted TTM
$-3.35
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-554,781,000
Inventory
$13,991,000
Receivables
$24,296,000
ST Investments
$50,342,000
EBIT TTM
$-47,962,000
Pretax Income TTM
$-52,828,000
Interest Exp TTM
$234,000
Analysts
9

Yahoo Snapshot (yfinance, live)

Total Revenue
$154,592,992
EBITDA
$-53,972,000
Free Cash Flow
$-36,145,376
Enterprise Value
$277,272,288
Total Cash
$128,557,000
Total Debt
$682,000
Shares Out
15,198,385
Trailing EPS
$-3.46
Book Value
$5.39
ROE
-47.0%
ROA
-18.9%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 92,390,000 -38,129,000 -37,709,000 206,073,000 49,707,000 156,459,000 -21,826,000
Dec 2024 15,936,000 -38,277,000 -46,304,000 213,575,000 42,229,000 170,389,000 -28,874,000
Dec 2023 6,155,000 -42,469,000 -62,724,000 254,171,000 44,013,000 206,359,000 -13,765,000
Dec 2022 13,164,000 -65,917,000 -190,454,000 312,131,231 68,668,371 237,064,127 14,515,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.67

Max Pain — expiry 2027-08-20 (volume-derived — Yahoo OI feed degraded)

max pain strike: $15.00 · spot: $10.35 · call volume: 755 · put volume: 6
Expected Move to 2027-08-20: ±$9.50 (91.79%) — implied range $0.85 – $19.85 · ATM straddle on $15.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
NWBO NORTHWEST BIOTHERAPEUTICS INC $250.73M $0.15 —
CAMP Camp4 Therapeutics Corp $251.02M $4.00 —
ENTA ENANTA PHARMACEUTICALS INC $253.10M $8.69 —
LFCR LIFECORE BIOMEDICAL, INC. \DE\ $242.22M $6.39 —
QTTB Q32 Bio Inc. $258.24M $8.63 —

News headlines (Yahoo Finance, 1h cache)

Prenetics Global Limited Q3 2026 Earnings Call Summary
2026-11-18 22:11 · Yahoo
What Prenetics Global (PRE) Said on Its Q3 Earnings Call
2026-11-18 18:14 · Yahoo
Prenetics’ IM8 Reports Q3 2026 Revenue Growth of 266% YoY; Earliest Customers Have Returned More Than 3x Their Acquisition Cost in Under Two Years; Reaffirms FY 2026 Total Revenue Guidance of $220–230
2026-11-18 13:01 · Yahoo
PRE: Hitting All the Right Notes
2026-11-18 12:49 · Yahoo
Prenetics’ IM8 Announces Three-Time GRAMMY-Winning DJ and Producer Diplo as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
2026-11-16 13:30 · Yahoo
Care Bears And Prenetics' IM8 Announce Global Partnership
2026-11-05 13:32 · Yahoo
Prenetics’ IM8 and Authentic Brands Group Announce 10-Year Exclusive Global Partnership to Create Care Bears by IM8; Authentic to Become Strategic Shareholder in Prenetics
2026-11-05 13:30 · Yahoo
PRE Announces Strategic Partnership
2026-11-05 11:00 · Yahoo
Prenetics’ IM8 Names Brian J. Rosin as Successor Chief Financial Officer
2026-11-03 14:05 · Yahoo
Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
2026-08-26 12:38 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.